Skip to main content
SpringerLink
Log in

Follicular Lymphoma and Mantle Cell Lymphoma

  • Chapter
  • First Online:
Book cover Neoplastic Hematopathology

Part of the book series: Contemporary Hematology ((CH))

  • 2260 Accesses

Abstract/Scope of Chapter

This chapter covers the commonly-encountered follicular lymphoma and the more aggressive but rare mantle cell lymphoma. These two B-cell lymphomas are predominantly lymph node-based but show characteristic patterns of spread to the bone marrow and gastrointestinal tract. Both lymphomas progress through recognizable histologic stages that are characterized by increasing number of large tumor cells and accumulation of cell cycle genetic defects. Follicular lymphoma however shows a more clear requirement for stromal-derived cytokine signals and B-cell receptor pathway dysregulation for full transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol 1998;9:717-20.

    Article  PubMed  CAS  Google Scholar 

  2. Chang KC, Huang GC, Jones D, Tsao CJ, Lee JY, Su IJ. Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors. Leuk Lymphoma 2004;45:1375-84.

    Article  PubMed  CAS  Google Scholar 

  3. Bende RJ, Smit LA, Bossenbroek JG, et al. Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 2003;162:105-13.

    Article  PubMed  CAS  Google Scholar 

  4. Sentani K, Maeshima AM, Nomoto J, et al. Follicular lymphoma of the duodenum: a clinicopathologic analysis of 26 cases. Jpn J Clin Oncol 2008;38:547-52.

    Article  PubMed  Google Scholar 

  5. Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol 2005;29:1490-6.

    Article  PubMed  Google Scholar 

  6. Melo JV, Robinson DS, De Oliveira MP, et al. Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma. J Clin Pathol 1988;41:951-9.

    Article  PubMed  CAS  Google Scholar 

  7. Hsi ED, Mirza I, Lozanski G, et al. A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences. Arch Pathol Lab Med 2004;128:863-8.

    PubMed  Google Scholar 

  8. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008.

    Google Scholar 

  9. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol 1983;1:187-92.

    Article  PubMed  CAS  Google Scholar 

  10. Martin AR, Weisenburger DD, Chan WC, et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 1995;85:3671-8.

    PubMed  CAS  Google Scholar 

  11. Hans CP, Weisenburger DD, Vose JM, et al. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood 2003;101:2363-7.

    Article  PubMed  CAS  Google Scholar 

  12. Metter GE, Nathwani BN, Burke JS, et al. Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol 1985;3:25-38.

    PubMed  CAS  Google Scholar 

  13. Lim DG, Nga ME, Tan LH, et al. Primary nodal follicular lymphoma with spindle cell features: a potential diagnostic pitfall. Histopathology 2008;53:120-2.

    Article  PubMed  Google Scholar 

  14. Mollejo M, Rodriguez-Pinilla MS, Montes-Moreno S, et al. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases. Am J Surg Pathol 2009;33:730-8.

    Google Scholar 

  15. Katzenberger T, Kalla J, Leich E, et al. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 2009;113:1053-61.

    Article  PubMed  CAS  Google Scholar 

  16. Yegappan S, Schnitzer B, Hsi ED. Follicular lymphoma with marginal zone differentiation: microdissection demonstrates the t(14;18) in both the follicular and marginal zone components. Mod Pathol 2001;14:191-6.

    Article  PubMed  CAS  Google Scholar 

  17. Goodlad JR, Batstone PJ, Hamilton D, Hollowood K. Follicular lymphoma with marginal zone differentiation: cytogenetic findings in support of a high-risk variant of follicular lymphoma. Histopathology 2003;42:292-8.

    Article  PubMed  CAS  Google Scholar 

  18. Torlakovic EE, Aamot HV, Heim S. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma. J Pathol 2006;209:258-64.

    Article  PubMed  CAS  Google Scholar 

  19. Kojima M, Yamanaka S, Yoshida T, et al. Histological variety of floral variant of follicular lymphoma. APMIS 2006;114:626-32.

    Article  PubMed  Google Scholar 

  20. Tiesinga JJ, Wu CD, Inghirami G. CD5+ follicle center lymphoma. Immunophenotyping detects a unique subset of “floral” follicular lymphoma. Am J Clin Pathol 2000;114:912-21.

    Article  PubMed  CAS  Google Scholar 

  21. Sotomayor EA, Shah IM, Sanger WG, Mark HF. In situ follicular lymphoma with a 14;18 translocation diagnosed by a multimodal approach. Exp Mol Pathol 2007;83:254-8.

    Article  PubMed  CAS  Google Scholar 

  22. Karube K, Guo Y, Suzumiya J, et al. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood 2007;109:3076-9.

    PubMed  CAS  Google Scholar 

  23. Bosga-Bouwer AG, Haralambieva E, Booman M, et al. BCL6 alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B. Genes Chromosomes Cancer 2005;44:301-4.

    Article  PubMed  CAS  Google Scholar 

  24. Guo Y, Karube K, Kawano R, et al. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous ­disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia 2005;19:1058-63.

    Article  PubMed  CAS  Google Scholar 

  25. Bosga-Bouwer AG, van Imhoff GW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003;101:1149-54.

    Article  PubMed  CAS  Google Scholar 

  26. Bacon CM, Ye H, Diss TC, et al. Primary follicular lymphoma of the testis and epididymis in adults. Am J Surg Pathol 2007;31:1050-8.

    Article  PubMed  Google Scholar 

  27. Finn LS, Viswanatha DS, Belasco JB, et al. Primary follicular lymphoma of the testis in childhood. Cancer 1999;85:1626-35.

    Article  PubMed  CAS  Google Scholar 

  28. Xie X, Sundram U, Natkunam Y, et al. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma. Mod Pathol 2008;21:653-9.

    Article  PubMed  CAS  Google Scholar 

  29. Morice WG, Kurtin PJ, Hodnefield JM, et al. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin Proc 2008;83:776-85.

    Article  PubMed  Google Scholar 

  30. Naresh KN. Nodal marginal zone B-cell lymphoma with prominent follicular colonization - difficulties in diagnosis: a study of 15 cases. Histopathology 2008;52:331-9.

    Article  PubMed  CAS  Google Scholar 

  31. Kojima M, Matsumoto M, Miyazawa Y, Shimizu K, Itoh H, Masawa N. Follicular lymphoma with prominent sclerosis (“sclerosing variant of follicular lymphoma”) exhibiting a mesenteric bulky mass resembling inflammatory pseudotumor. Report of three cases. Pathol Oncol Res 2007; 13:74-7.

    Article  PubMed  Google Scholar 

  32. Fenton JA, Vaandrager JW, Aarts WM, et al. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells. Blood 2002;99:716-8.

    Article  PubMed  CAS  Google Scholar 

  33. Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18-29.

    Article  PubMed  CAS  Google Scholar 

  34. Aster JC, Kobayashi Y, Shiota M, Mori S, Sklar J. Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 1992;141:291-9.

    PubMed  CAS  Google Scholar 

  35. Ruminy P, Jardin F, Picquenot JM, et al. S(mu) mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells. Blood 2008;112:1951-9.

    Article  PubMed  CAS  Google Scholar 

  36. Tracey L, Perez-Rosado A, Artiga MJ, et al. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 2005;206:123-34.

    Article  PubMed  CAS  Google Scholar 

  37. Husson H, Carideo EG, Neuberg D, et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002;99:282-9.

    Article  PubMed  CAS  Google Scholar 

  38. Vanasse GJ, Winn RK, Rodov S, et al. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma. Mol Cancer Res 2004;2:620-31.

    PubMed  CAS  Google Scholar 

  39. Lossos IS, Levy R, Alizadeh AA. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 2004;18:1775-9.

    Article  PubMed  CAS  Google Scholar 

  40. Cattoretti G, Buttner M, Shaknovich R, Kremmer E, Alobeid B, Niedobitek G. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 2006;107:3967-75.

    Article  PubMed  CAS  Google Scholar 

  41. Jaye DL, Iqbal J, Fujita N, et al. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation. J Pathol 2007;213:106-15.

    Article  PubMed  CAS  Google Scholar 

  42. Natkunam Y, Zhao S, Mason DY, et al. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 2007;109:1636-42.

    Article  PubMed  CAS  Google Scholar 

  43. Montes-Moreno S, Roncador G, Maestre L, et al. Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas. Blood 2008;111:351-8.

    Article  PubMed  CAS  Google Scholar 

  44. Natkunam Y, Lossos IS, Taidi B, et al. Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood 2005;105:3979-86.

    Article  PubMed  CAS  Google Scholar 

  45. Scott CL, Gil J, Hernando E, et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci U S A 2007;104:5389-94.

    Article  PubMed  CAS  Google Scholar 

  46. McDonnell TJ, Nunez G, Platt FM, et al. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 1990;10:1901-7.

    PubMed  CAS  Google Scholar 

  47. Irish JM, Czerwinski DK, Nolan GP, Levy R. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood 2006;108:3135-42.

    Article  PubMed  CAS  Google Scholar 

  48. Davies AJ, Rosenwald A, Wright G, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol 2007;136:286-93.

    Article  PubMed  CAS  Google Scholar 

  49. Fitzgibbon J, Iqbal S, Davies A, et al. Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia 2007;21:1514-20.

    Article  PubMed  CAS  Google Scholar 

  50. Cheung KJ, Shah SP, Steidl C, et al. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood 2009;113:137-48.

    Article  PubMed  CAS  Google Scholar 

  51. d’Amore F, Chan E, Iqbal J, et al. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. Clin Cancer Res 2008;14:7180-7.

    Article  PubMed  CAS  Google Scholar 

  52. Martinez-Climent JA, Alizadeh AA, Segraves R, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 2003;101:3109-17.

    Article  PubMed  CAS  Google Scholar 

  53. Al-Assar O, Rees-Unwin KS, Menasce LP, et al. Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes. Br J Haematol 2006;133:612-21.

    Article  PubMed  CAS  Google Scholar 

  54. Allen JE, Hough RE, Goepel JR, et al. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol 2002;116:291-8.

    Article  PubMed  CAS  Google Scholar 

  55. Bea S, Tort F, Pinyol M, et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001;61:2409-12.

    PubMed  CAS  Google Scholar 

  56. Davies AJ, Lee AM, Taylor C, et al. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia 2005;19:1459-65.

    Article  PubMed  CAS  Google Scholar 

  57. O’Shea D, O’Riain C, Taylor C, et al. The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. Blood 2008;112:3126-9.

    Article  PubMed  CAS  Google Scholar 

  58. Greiner TC, Dasgupta C, Ho VV, et al. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci U S A 2006;103:2352-7.

    Article  PubMed  CAS  Google Scholar 

  59. Fang NY, Greiner TC, Weisenburger DD, et al. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc Natl Acad Sci U S A 2003;100:5372-7.

    Article  PubMed  CAS  Google Scholar 

  60. Ferreira BI, Garcia JF, Suela J, et al. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 2008;93:670-9.

    Article  PubMed  CAS  Google Scholar 

  61. Goff LK, Neat MJ, Crawley CR, et al. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma. Br J Haematol 2000;111:618-25.

    Article  PubMed  CAS  Google Scholar 

  62. Mohamed AN, Palutke M, Eisenberg L, Al-Katib A. Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant. Cancer Genet Cytogenet 2001;126:45-51.

    Article  PubMed  CAS  Google Scholar 

  63. Knezevich S, Ludkovski O, Salski C, et al. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas. Leukemia 2005;19:659-63.

    PubMed  CAS  Google Scholar 

  64. Sasaki Y, Derudder E, Hobeika E, et al. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 2006;24:729-39.

    Article  PubMed  CAS  Google Scholar 

  65. Fukuhara N, Tagawa H, Kameoka Y, et al. Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma. Cancer Sci 2006;97:499-504.

    Article  PubMed  CAS  Google Scholar 

  66. Reader JC, Zhao XF, Butler MS, Rapoport AP, Ning Y. REL-positive double minute chromosomes in follicular lymphoma. Leukemia 2006;20:1624-6.

    Article  PubMed  CAS  Google Scholar 

  67. Starczynowski DT, Trautmann H, Pott C, et al. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL’s in vitro transforming activity. Oncogene 2007;26:2685-94.

    Article  PubMed  CAS  Google Scholar 

  68. Ame-Thomas P, Maby-El Hajjami H, Monvoisin C, et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood 2007;109:693-702.

    Article  PubMed  CAS  Google Scholar 

  69. Chang KC, Huang X, Medeiros LJ, Jones D. Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma. J Pathol 2003;201:404-12.

    Article  PubMed  Google Scholar 

  70. Lee AM, Clear AJ, Calaminici M, et al. Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 2006;24:5052-9.

    Article  PubMed  CAS  Google Scholar 

  71. Glas AM, Knoops L, Delahaye L, et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007;25:390-8.

    Article  PubMed  CAS  Google Scholar 

  72. de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005;23:6358-63.

    Article  PubMed  Google Scholar 

  73. Salles GA. Clinical features, prognosis and treatment of follicular lymphoma. Hematology Am Soc Hematol Educ Program 2007;2007:216-25.

    Article  Google Scholar 

  74. Montoto S, Davies AJ, Matthews J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007;25:2426-33.

    Article  PubMed  Google Scholar 

  75. Friedberg JW, Taylor MD, Cerhan JR, et al. Follicular lymphoma in the United States: first report of the National Lymphocare Study. J Clin Oncol 2009;27:1202-8.

    Google Scholar 

  76. Koster A, Tromp HA, Raemaekers JM, et al. The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma. Haematologica 2007;92:184-90.

    Article  PubMed  Google Scholar 

  77. Logsdon MD, Meyn RE Jr, Besa PC, et al. Apoptosis and the Bcl-2 gene family - patterns of expression and prognostic value in stage I and II follicular center lymphoma. Int J Radiat Oncol Biol Phys 1999;44:19-29.

    Article  PubMed  CAS  Google Scholar 

  78. Leich E, Hartmann EM, Burek C, Ott G, Rosenwald A. Diagnostic and prognostic significance of gene expression profiling in lymphomas. APMIS 2007;115:1135-46.

    Article  PubMed  CAS  Google Scholar 

  79. Klapper W, Hoster E, Rolver L, et al. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group. J Clin Oncol 2007;25:3330-6.

    Article  PubMed  Google Scholar 

  80. Farinha P, Masoudi H, Skinnider BF, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005;106:2169-74.

    Article  PubMed  CAS  Google Scholar 

  81. Canioni D, Salles G, Mounier N, et al. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 2008;26:440-6.

    Article  PubMed  CAS  Google Scholar 

  82. Carreras J, Lopez-Guillermo A, Fox BC, et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006;108:2957-64.

    Article  PubMed  CAS  Google Scholar 

  83. Kelley T, Beck R, Absi A, Jin T, Pohlman B, Hsi E. Biologic predictors in follicular lymphoma: importance of markers of immune response. Leuk Lymphoma 2007;48:2403-11.

    Article  PubMed  Google Scholar 

  84. Marcus R, Imrie K, Solal-Celigny P, et al. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol 2008;26:4579-86.

    Article  PubMed  CAS  Google Scholar 

  85. Alvaro T, Lejeune M, Salvado MT, et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 2006;24:5350-7.

    Article  PubMed  Google Scholar 

  86. Bowman A, Jones D, Medeiros LJ, Luthra R. Quantitative PCR detection of t(14;18) bcl-2/JH fusion sequences in follicular lymphoma patients: comparison of peripheral blood and bone marrow aspirate samples. J Mol Diagn 2004;6:396-400.

    Article  PubMed  CAS  Google Scholar 

  87. Mandigers CM, Meijerink JP, van’t Veer MB, Mensink EJ, Raemaekers JM. Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma. Ann Hematol 2003;82:743-9.

    Google Scholar 

  88. Paszkiewicz-Kozik E, Kulik J, Fabisiewicz A, et al. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma. Med Oncol 2009;26:16-21.

    Article  PubMed  CAS  Google Scholar 

  89. Tort F, Camacho E, Bosch F, Harris NL, Montserrat E, Campo E. Familial lymphoid neoplasms in patients with mantle cell lymphoma. Haematologica 2004;89:314-9.

    PubMed  CAS  Google Scholar 

  90. De Oliveira MS, Jaffe ES, Catovsky D. Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. J Clin Pathol 1989;42:962-72.

    Article  PubMed  Google Scholar 

  91. Schlette E, Lai R, Onciu M, Doherty D, Bueso-Ramos C, Medeiros LJ. Leukemic mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases. Mod Pathol 2001;14: 1133-40.

    Article  PubMed  CAS  Google Scholar 

  92. Weisenburger DD, Vose JM, Greiner TC, et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol 2000;64:190-6.

    Article  PubMed  CAS  Google Scholar 

  93. Weisenburger DD, Kim H, Rappaport H. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma. Cancer 1982;49:1429-38.

    Article  PubMed  CAS  Google Scholar 

  94. Majlis A, Pugh WC, Rodriguez MA, Benedict WF, Cabanillas F. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol 1997;15:1664-71.

    PubMed  CAS  Google Scholar 

  95. Yatabe Y, Suzuki R, Matsuno Y, et al. Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases. Pathol Int 2001;51:747-61.

    Article  PubMed  CAS  Google Scholar 

  96. Zanetto U, Dong H, Huang Y, et al. Mantle cell lymphoma with aberrant expression of CD10. Histopathology 2008;53:20-9.

    Article  PubMed  CAS  Google Scholar 

  97. Schlette E, Fu K, Medeiros LJ. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. Am J Clin Pathol 2003;120:760-6.

    Article  PubMed  CAS  Google Scholar 

  98. Xu Y, McKenna RW, Kroft SH. Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study. Am J Clin Pathol 2002;117:291-300.

    Article  PubMed  Google Scholar 

  99. Wlodarska I, Dierickx D, Vanhentenrijk V, et al. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. Blood 2008;111:5683-90.

    Article  PubMed  CAS  Google Scholar 

  100. Ott G, Kalla J, Ott MM, et al. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 1997;89:1421-9.

    PubMed  CAS  Google Scholar 

  101. Yared MA, Khoury JD, Medeiros LJ, Rassidakis GZ, Lai R. Activation status of the JAK/STAT3 pathway in mantle cell lymphoma. Arch Pathol Lab Med 2005;129:990-6.

    PubMed  CAS  Google Scholar 

  102. Ford RJ, Shen L, Lin-Lee YC, et al. Development of a murine model for blastoid variant mantle-cell lymphoma. Blood 2007;109:4899-906.

    Article  PubMed  CAS  Google Scholar 

  103. Raty R, Franssila K, Jansson SE, Joensuu H, Wartiovaara-Kautto U, Elonen E. Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma. Eur J Cancer 2003;39:321-9.

    Article  PubMed  CAS  Google Scholar 

  104. Hao S, Sanger W, Onciu M, Lai R, Schlette EJ, Medeiros LJ. Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol 2002;15:1266-72.

    Article  PubMed  Google Scholar 

  105. Izban KF, Alkan S, Singleton TP, Hsi ED. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma. Arch Pathol Lab Med 2000;124:1457-62.

    PubMed  CAS  Google Scholar 

  106. de Vos S, Krug U, Hofmann WK, et al. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV. Diagn Mol Pathol 2003;12:35-43.

    Article  PubMed  Google Scholar 

  107. Ott G, Kalla J, Hanke A, et al. The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. Leuk Lymphoma 1998;32:55-63.

    PubMed  CAS  Google Scholar 

  108. Neben K, Ott G, Schweizer S, et al. Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma. Int J Cancer 2007;120:1669-77.

    Article  PubMed  CAS  Google Scholar 

  109. Rummel MJ, de Vos S, Hoelzer D, Koeffler HP, Hofmann WK. Altered apoptosis pathways in mantle cell lymphoma. Leuk Lymphoma 2004;45:49-54.

    Article  PubMed  CAS  Google Scholar 

  110. Weinkauf M, Christopeit M, Hiddemann W, Dreyling M. Proteome- and microarray-based expression analysis of lymphoma cell lines identifies a p53-centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma. Electrophoresis 2007;28:4416-26.

    Article  PubMed  CAS  Google Scholar 

  111. Fayad L, Thomas D, Romaguera J. Update of the M.D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas. Clin Lymphoma Myeloma 2007;8(Suppl 2):S57-62.

    Article  Google Scholar 

  112. Garcia M, Romaguera JE, Inamdar KV, Rassidakis GZ, Medeiros LJ. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine. Cancer 2009;115:1041-8.

    Article  PubMed  CAS  Google Scholar 

  113. Raty R, Franssila K, Joensuu H, Teerenhovi L, Elonen E. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol 2002;69:11-20.

    Article  PubMed  Google Scholar 

  114. Kienle D, Katzenberger T, Ott G, et al. Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors. J Clin Oncol 2007;25:2770-7.

    Article  PubMed  CAS  Google Scholar 

  115. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-97.

    Article  PubMed  CAS  Google Scholar 

  116. Schrader C, Meusers P, Brittinger G, et al. Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients. Virchows Arch 2006;448:151-9.

    Article  PubMed  Google Scholar 

  117. Samaha H, Dumontet C, Ketterer N, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia 1998;12:1281-7.

    Article  PubMed  CAS  Google Scholar 

  118. Oinonen R, Franssila K, Teerenhovi L, Lappalainen K, Elonen E. Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients. Eur J Cancer 1998;34:329-36.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematopathology, M. D. Anderson Cancer Center, The University of Texas, Houston, TX, USA

    Dan Jones

Authors
  1. Dan Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dan Jones .

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, The University of Texas, Holcombe Blvd. 1515 , Houston, 77030, U.S.A.

    Dan Jones

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Jones, D. (2010). Follicular Lymphoma and Mantle Cell Lymphoma. In: Jones, D. (eds) Neoplastic Hematopathology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-384-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-384-8_16

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-383-1

  • Online ISBN: 978-1-60761-384-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation